Human microbiome and diseases: a metagenomic approach

Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease

Volumn , Issue , 2013, Pages 235-249

  Collado, M C ^a,b   D'Auria, G ^c   Mira, A ^c   Francino, M P ^c,d  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b UNIVERSITY OF TURKU   (Finland)

^c Genomics and Health Centre for Public Health Research (CSISP)   (Spain)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885118601     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397154-8.00029-4     Document Type: Chapter

References (69)

1. Abnet C.C., Qiao Y.L., Mark S.D., Dong Z.W., Taylor P.R., Dawsey S.M. Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Causes & Control 2001, 12:847-854.
2. Alcaraz L.D., Belda-Ferre P., Cabrera-Rubio R., et al. Identifying a healthy oral microbiome through metagenomics. Clinical Microbiology and Infection 2012, 18(4):54-57.
3. Bäckhed F., Ding H., Wang T., et al. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(44):15718-15723.
4. Behr M.A., Kapur V. The evidence for Mycobacterium paratuberculosis in Crohn's disease. Current Opinion in Gastroenterology 2008, 24:17-21.
5. Bik E.M., Eckburg P.B., Gill S.R., et al. Molecular analysis of the bacterial microbiota in the human stomach. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(3):732-737.
6. Bik E.M., Long C.D., Armitage G.C., et al. Bacterial diversity in the oral cavity of 10 healthy individuals. The ISME Journal: Multidisciplinary Journal of Microbial Ecology 2010, 4(8):962-974.
7. Bjorksten B., Naaber P., Sepp E., Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clinical and Experimental Allergy 1999, 29:342-346.
8. Braun-Fahrlander C., Riedler J., Herz U., et al. Environmental exposure to endotoxin and its relation to asthma in school age children. The New England Journal of Medicine 2002, 347:869-877.
9. Cani P.D., Neyrinck A.M., Fava F., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
10. Cesaro C., Tiso A., Del Prete A., et al. Gut microbiota and probiotics in chronic liver diseases. Digestive and Liver Disease 2011, 43(6):431-438. 10.1016/j.dld.2010.10.015.
11. Collado M.C., Isolauri E., Salminen S., Sanz Y. The impact of probiotic on gut health. Current Drug Metabolism 2009, 10(1):68-78.
12. Collado M.C., Isolauri E., Laitinen K., Salminen S. Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. American Journal of Clinical Nutrition 2010, 92(5):1023-1030.
13. Delzenne N.M., Cani P.D. Gut microbiota and the pathogenesis of insulin resistance. Current Diabetes Reports 2011, 11(3):154-159. 10.1007/s11892-011-0191-1.
14. Dominguez-Bello M.G., Costello E.K., Contreras M., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:11971-11975.
15. Dowlati Y., Herrmann N., Swardfager W., et al. A meta-analysis of cytokines in major depression. Biological Psychiatry 2010, 67:446-457.
16. Duncan S.H., Lobley G.E., Holtrop G., et al. Human colonic microbiota associated with diet, obesity and weight loss. International Journal of Obesity 2008, 32:1720-1724.
17. FAO/WHO, 2002. Guidelines for the evaluation of probiotics in food. Food and Agricultural Organization of the United Nations and World Health Organization. Working Group Report 2002.
18. Fava F., Danese S. Intestinal microbiota in inflammatory bowel disease: friend of foe?. World Journal of Gastroenterology 2011, 17(5):557-566.
19. Floch M.H., Walker W.A. Advances in clinical use of probiotics. Journal of Clinical Gastroenterology 2008, 42(2):S45.
20. Garg A.X., Pope J.E., Thiessen-Philbrook H., Clark W.F., Ouimet J. Walkerton Health Study Investigators. Arthritis risk after acute bacterial gastroenteritis. Rheumatology (Oxford) 2008, 47(2):200-204.
21. Gosalbes M.J., Durbán A., Pignatelli M., et al. Metatranscriptomic approach to analyze the functional human gut microbiota. PloS One 2011, 6(3):e17447.
22. Grice E.A., Segre J.A. The skin microbiome. Nature Reviews Microbiology 2011, 9(4):244-253.
23. Guarner F., Bourdet-Sicard R., Brandtzaeg P., et al. Mechanisms of disease: the hygiene hypothesis revisited. Nature Reviews. Gastroenterology & Hepatology 2006, 3:275-284.
24. Gueimonde M., Ouwehand A., Huhtinen H., Salminen E., Salminen S. Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World Journal of Gastroenterology 2007, 13(29):3985-3989.
25. Heijtz R.D., Wang S., Anuar F., et al. Normal gut microbiota modulates brain development and behavior. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(7):3047-3052.
26. Isolauri E., Kalliomäki M., Laitinen K., Salminen S. Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease. Current Pharmaceutical Design 2008, 14(14):1368-1375.
27. Jimenez E., Marin M.L., Martin R., et al. Is meconium from healthy newborns actually sterile?. Research in Microbiology 2008, 159:187-193.
28. Kalliomäki M., Kirjavainen P., Eerola E., Kero P., Salminen S., Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. The Journal of Allergy and Clinical Immunology 2001, 107:129-134.
29. Kalliomäki M., Collado M.C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict later weight-gain?. American Journal of Clinical Nutrition 2008, 87:534-538.
30. Kirjavainen P.V., Pautler S., Baroja M.L., et al. Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections. Clinical and Vaccine Immunology 2009, 16(1):29-36.
31. Koenig J.E., Spor A., Scalfone N., et al. Microbes and health sackler colloquium: succession of microbial consortia in the developing infant gut microbiome. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:4578-4585.
32. Kurokawa K., Itoh T., Kuwahara T., et al. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Research 2007, 14(4):169-181.
33. Lamont R., Sobel J., Akins R., et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG : An International Journal of Obstetrics and Gynaecology 2011, 118(5):533-549.
34. Larsen N., Vogensen F.K., van den Berg F.W., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS One 2010, 5(2):e9085.
35. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(31):11070-11075.
36. Manichanh C., Rigottier-Gois L., Bonnaud E., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55(2):205-211.
37. Murray C.S., Tannock G.W., Simon M.A., et al. Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study. Clinical and Experimental Allergy 2005, 35:741-745.
38. Nelson D.E., Van Der Pol B., Dong Q., et al. Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PloS One 2010, 5(11):e14116.
39. Neu J., Lorca G., Kingma S.D., Triplett E.W. The intestinal microbiome: relationship to type 1 diabetes. Endocrinology and Metabolism Clinics of North America 2010, 39(3):563-571.
40. Neufeld K.A., Foster J.A. Effects of gut microbiota on the brain: implications for psychiatry. Journal of Psychiatry & Neuroscience 2009, 34(3):230-231.
41. Noverr M.C., Huffnagle G.B. The 'microflora hypothesis' of allergic diseases. Clinical and Experimental Allergy 2005, 35:1511-1520.
42. Ochoa-Repáraz J., Mielcarz D.W., Begum-Haque S., Kasper L.H. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Annals of Neurology 2011, 69(2):240-247.
43. Palmer C., Bik E.M., DiGiulio D.B., Relman D.A., Brown P.O. Development of the human infant intestinal microbiota. PLoS Biology 2007, 5:e177.
44. Paster B.J., Boches S.K., Galvin J.L., et al. Bacterial diversity in human subgingival plaque. Journal of Bacteriology 2001, 183:3770-3783.
45. Penders J., Stobberingh E.E., Thijs C., et al. Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clinical and Experimental Allergy 2006, 36:1602-1608.
46. Penders J., Thijs C., Vink C., et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118:511-521.
47. Penders J., Stobberingh E.E., van den Brandt P.A., Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007, 62:1223-1236.
48. Qin J., Li R., Raes J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464(7285):59-65.
49. Rautava S., Ruuskanen O., Ouwehand A., Salminen S., Isolauri E. The hygiene hypothesis of atopic disease - an extended version. Journal of Pediatric Gastroenterology and Nutrition 2004, 38:378-388.
50. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?. Immunology 2004, 112:352-363.
51. Santacruz A., Collado M.C., García-Valdés L., et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. British Journal of Nutrition 2010, 104(1):83-92.
52. Schwiertz A., Taras D., Schäfer K., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010, 18(1):190-195.
53. Sekirov I., Russell S.L., Antunes L.C., Finlay B.B. Gut microbiota in health and disease. Physiological Reviews 2010, 90(3):859-904.
54. Sjogren Y.M., Jenmalm M.C., Bottcher M.F., Bjorksten B., Sverremark-Ekstrom E. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clinical and Experimental Allergy 2009, 39:518-526.
55. Spear G.T., Gilbert D., Landay A.L., et al. Pyrosequencing of the genital microbiotas of HIV-seropositive and -seronegative women reveals Lactobacillus iners as the predominant Lactobacillus Species. Applied and Environmental Microbiology 2011, 77(1):378-381.
56. Stebbings S.M., Taylor C., Tannock G.W., Baird M.A., Highton J. The immune response to autologous bacteroides in ankylosing spondylitis is characterized by reduced interleukin 10 production. Journal of Rheumatology 2009, 36(4):797-800.
57. Stecher B., Hardt W.-D.D. The role of microbiota in infectious disease. Trends in Microbiology 2008, 16(3):107-114.
58. Strachan D.P. Hay fever, hygiene, and household size. British Medical Journal 1989, 299(6710):1259-1260.
59. Tana C., Umesaki Y., Imaoka A., Handa T., Kanazawa M., Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterology and Motility 2010, 22(5):512-519.
60. Tiihonen K., Ouwehand A.C., Rautonen N. Human intestinal microbiota and healthy ageing. Ageing Research Reviews 2010, 9(2):107-116.
61. Toivanen P. Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis. Annals of the Rheumatic Diseases 2003, 62(9):807-811.
62. Tsai F., Coyle W.J. The microbiome and obesity: is obesity linked to our gut flora?. Current Gastroenterology Reports 2009, 11(4):307-313.
63. Turnbaugh P.J., Gordon J.I. The core gut microbiome, energy balance and obesity. The Journal of Physiology 2009, 587(Pt 17):4153-4158.
64. Vaishampayan P.A., Kuehl J.V., Froula J.L., Morgan J.L., Ochman H., Francino M.P. Comparative metagenomics and population dynamics of the gut microbiota in mother and infant. Genome Biology and Evolution 2010, 2:53-66.
65. Vallès Y., Gosalbes M.J., de Vries L.E., Abellán J.J., Francino M.P. Metagenomics and development of the gut microbiota in infants. Clinical Microbiology and Infection 2012, 18(4):21-26.
66. Vanderploeg R., Panaccione R., Ghosh S., Rioux K. Influences of intestinal bacteria in human inflammatory bowel disease. Infectious Disease Clinics of North America 2010, 24(4):977-993.
67. Vanner S. The small intestinal bacterial overgrowth irritable bowel syndrome hypothesis: implications for treatment. Gut 2008, 57(9):1315-1321.
68. Yamini D., Pimentel M. Irritable bowel syndrome and small intestinal bacterial overgrowth. Journal of Clinical Gastroenterology 2010, 44(10):672-675.
69. Zaura E., Keijser B.J., Huse S.M., Crielaard W. Defining the healthy 'core microbiome' of oral microbial communities. BMC Microbiology 2009, 9:259.